News Release

For immediate release

April 24, 2019
EPS International Holdings Co., Ltd.
George Clinical Pty Ltd

EPS International and George Clinical Form StrategicPartnership for the Asia-Pacific Region
EPS International Holdings Co., Ltd. (HQ: Tokyo, Japan; Representative Director and President: Hisashi
Tanaka; "EPSI" hereafter) and George Clinical Pty Ltd (HQ: Sydney, Australia; Executive Chairman:Glenn Kerkhof; "George Clinical" hereafter) announced today that they have reached an agreement
on a strategic partnership that will enhance their combined service offerings in Asia-Pacific, the world’s
most populous region, as well as worldwide for their respective clients.
“EPSI aims to become the best partner for global expansion of pharmaceutical or medical device
development focused on Asia-Pacific, “ Dr. Hisashi Tanaka, Representative Director and CEO of EPS
International said. “I am so excited with this strategic partnership between George Clinical and EPSI
since it enables EPSI to provide our clients with further value-added services. We will create morerobust capabilities when it comes to quality service provision in Asia-Pacific countries as we leverage
George Clinical’s excellent scientific leadership and extensive global investigator networks.”“The partnership with EPSI enables George Clinical to manage high quality clinical trials across theentire Asia-Pacific region, including Japan, the third largest pharmaceutical market in the world,” said
Glenn Kerkhof, Executive Chairman of George Clinical. “George Clinical was one of the firstorganizations to truly embrace the opportunities of conducting clinical trials across the Asia-Pacificregion. As the region has developed into a sophisticated and desirable clinical trial location, so too hasGeorge Clinical developed into a highly-adaptable and scientifically led CRO, both regionally andglobally. With the addition of EPSI’s leading service provision in Japan, we will further enhance ourcustomer experience while pursuing our strategic growth objectives to be a leading CRO partner in theregion, providing global capabilities, and extending our ability to deliver early and late phase
operational expertise deeper into Asia-Pacific.”
The strategic partnership will see EPSI deliver clinical trial services for George Clinical clients in Japan.
George Clinical will provide clinical trial services for EPSI and its Japanese customers across Asia, theUnited States and Europe. In Asia, both companies will come together to provide a seamless operating
capability for clinical trials across the Asia-Pacific region with the exception of China where both EPSIand George Clinical will maintain an independent operating presence.
EPSI will continue to focus on creating new services which contribute to the advancement of thehealthcare industry supporting the George Clinical mission of improving the health of millions ofpeople worldwide through world-class scientific leadership and therapeutic strengths.
END OF NEWS RELEASE

News Release

About EPS International
Since its establishment in 1991 as one of pioneering CROs, EPS Group has been a Healthcare Solution
Provider to pharmaceutical companies, medical device manufacturers, hospitals and clinics, and academia
with various solutions from development to marketing, sales, consultation covering Asia centered in China
and new values created in big data & AI, regenerative medicine, etc. The strength of EPSI lies in the factthat it has the greatest presence in Japan. In Asia, the company has multiple overseas offices and has
focused particularly on solidifying its sites in the respective Asian countries, providing clinical development
support services as well as SMO services.
Contact:
Website:LinkedIn:

info@epsi-global.com
https://www.epsi-global.com/index.html
https://www.eps-holdings.co.jp/en/
https://www.linkedin.com/company/3672776/admin/[For inquiries related to this news release]
Takihiro Hirasawa
Corporate Officer, Head of Asia Business Unit
Tel: (+81) 03-5804-5049 E-mail: info@epsi-global.com
About George ClinicalGeorge Clinical is a leading independent Asia-Pacific and US-based contract research organization (CRO)with global capabilities differentiated by scientific leadership, innovation and extensive investigator
networks. With 20 years’ experience in the delivery of quality clinical trials, staff operating in 16 countries,and with significant operations in the USA, China, India and the broader Asia-Pacific region, George Clinicalprovides the full range of clinical trial services to biopharmaceutical, medical device, and diagnostic
customers, for all trial phases, registration and post-marketing trials.
Contact:
Website:LinkedIn:Twitter:
Facebook:mreabold@georgeclinical.com
https://www.georgeclinical.com
https://www.linkedin.com/company/george-clinical-pty-ltd
https://twitter.com/george_clinicalhttps://www.facebook.com/georgeclinical[For inquiries related to this news release]
Donna McDonnell
Business Development Administrator
Mobile : +1-901-229-5345
E-mail : dmcdonnell@georgeclinical.com